Background & Objectives: Although neuro-intensive patients share many common sedation goals with general ICU patients, some requirements are unique to the NICU population, such as maintaining adequate cerebral perfusion pressure (CPP), while controlling intracranial pressure (ICP) and mean arterial pressure (MAP). Our primary objectives were to assess the effect of dexmedetomidine as a sedative in ICU, by time to achieve desired RASS score and duration of time till RASS was maintained. Our secondary objectives were to assess the effect of dexmedetomidine on systemic hemodynamics of acute TBI patients, and its effect on ICP , CPP and neurological status, and evaluation of the need for supplementary sedation.
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Materials & Methods:
We compared the effect of 0.2-0.7µg/kg/hr dexmedetomidine infusion (Group D) to a standard sedative infusion of fentanyl 0.2-1 µg/kg/hr and midazolam (Group C) 0.02-0.07mg/kg/hr in 11 consecutive patients of Traumatic Brain Injury(TBI) admitted to the neurosurgical intensive care unit (NICU) in crossover alternation for the first 48 hours after admission, titrating sedation to the Richmond Agitation-Sedation Scale(RASS).
Results: Patient demographics were well matched between the two groups. Hemodynamics, heart rate, mean arterial pressure (HR, MAP) and intracranial pressure (ICP) along with cerebral perfusion pressure (CPP) were maintained within (p=0.472, 0.219, 0.328, and 0.165) and between the groups (p=0.096, 0.432, 0.478, 0.175 respectively) and the differences were not statistically significant. Patients in Group D had similar RASS scores to those of Group C (p=0.894). GCS score correlated with RASS score in Group D (p= 0.467, p= 0.021) and Group C(p=0.654, p= 0.001). Amount and number of rescue boli of sedation with midazolam were similar in both the groups (n=3, p=0.463). No adverse effects requiring rescue interventions were seen in either group.
Conclusion: Dexmedetomidine is a safe alternative to conventional fentanyl and midazolam sedative infusion for TBI patients admitted to Neurosurgical Intensive Care Unit. It maintains both cardiovascular (HR, MAP) as well as cerebral (ICP ,CPP)dynamics, paving the way for future exploration of dexmedetomidine for sedation for neurotrauma patients.
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